Ophthalmology Equipment Segmentation
The market is segmented by end-user into hospitals, clinics, and others. Among these segments, the clinics segment is projected to hold the largest market share by the end of 2021. The growth of the segment can be attributed to the increasing availability of private clinics which are operated by numerous ophthalmologists, along with the growing need amongst these clinics for ophthalmology equipment.
Our in-depth analysis of the global market includes the following segments
|
By Function of Product |
|
|
By End-User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of ophthalmology equipment is assessed at USD 72.29 billion.
Ophthalmology Equipment Market size was valued at USD 69.29 billion in 2024 and is likely to cross USD 132.28 billion by 2037, registering more than 5.1% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is set to hold largest revenue share by 2037, attributed to growing geriatric population in the region and need amongst individuals for affordable eye care.
The major players in the market are Novartis AG, Bausch & Lomb, NIDEK CO. LTD., ZEISS International, HOYA Corporation, Pfizer Inc., AbbVie Inc. (Allergan), Santen Pharmaceutical Co., Ltd., and others.
